SMYD2A Antikörper (Middle Region)
-
- Target Alle SMYD2A Antikörper anzeigen
- SMYD2A (SET and MYND Domain Containing 2a (SMYD2A))
-
Bindungsspezifität
- Middle Region
-
Reaktivität
- Human, Maus, Ratte, Rind (Kuh), Hund, Pferd, Kaninchen, Meerschweinchen, Schwein, Zebrafisch (Danio rerio)
-
Wirt
- Kaninchen
-
Klonalität
- Polyklonal
-
Konjugat
- Dieser SMYD2A Antikörper ist unkonjugiert
-
Applikation
- Western Blotting (WB), Chromatin Immunoprecipitation (ChIP)
- Sequenz
- SMWLKLGRLY MGLEHKAAGE KALKKAIAIM EVAHGKDHPY ISEIKQEIES
- Homologie
- Cow: 100%, Dog: 100%, Guinea Pig: 93%, Horse: 100%, Human: 100%, Mouse: 100%, Pig: 100%, Rabbit: 100%, Rat: 100%, Zebrafish: 86%
- Produktmerkmale
- This is a rabbit polyclonal antibody against SMYD2. It was validated on Western Blot using a cell lysate as a positive control.
- Aufreinigung
- Affinity Purified
- Immunogen
- The immunogen is a synthetic peptide directed towards the middle region of human SMYD2
- Top Product
- Discover our top product SMYD2A Primärantikörper
-
-
- Applikationshinweise
- Optimal working dilutions should be determined experimentally by the investigator.
- Kommentare
-
Antigen size: 433 AA
- Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
- Format
- Liquid
- Konzentration
- Lot specific
- Buffer
- Liquid. Purified antibody supplied in 1x PBS buffer with 0.09 % (w/v) sodium azide and 2 % sucrose.
- Konservierungsmittel
- Sodium azide
- Vorsichtsmaßnahmen
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
- Handhabung
- Avoid repeated freeze-thaw cycles.
- Lagerung
- -20 °C
- Informationen zur Lagerung
- For short term use, store at 2-8°C up to 1 week. For long term storage, store at -20°C in small aliquots to prevent freeze-thaw cycles.
-
-
Primary central nervous system lymphoma in Japan: changes in clinical features, treatment, and prognosis during 1985-2004." in: Neuro-oncology, Vol. 10, Issue 4, pp. 560-8, (2008) (PubMed).
: "
-
Primary central nervous system lymphoma in Japan: changes in clinical features, treatment, and prognosis during 1985-2004." in: Neuro-oncology, Vol. 10, Issue 4, pp. 560-8, (2008) (PubMed).
-
- Target
- SMYD2A (SET and MYND Domain Containing 2a (SMYD2A))
- Andere Bezeichnung
- SMYD2 (SMYD2A Produkte)
- Synonyme
- HSKM-B antikoerper, KMT3C antikoerper, ZMYND14 antikoerper, 1110020E07Rik antikoerper, 4930402C15 antikoerper, Zmynd14 antikoerper, smyd2-a antikoerper, im:7146196 antikoerper, smyd2 antikoerper, wu:fc02f02 antikoerper, zgc:110553 antikoerper, si:dkey-121j17.3 antikoerper, zgc:136609 antikoerper, SET and MYND domain containing 2 antikoerper, SET and MYND domain containing 2 S homeolog antikoerper, SET and MYND domain containing 2a antikoerper, SET and MYND domain containing 2b antikoerper, SMYD2 antikoerper, Smyd2 antikoerper, smyd2.S antikoerper, smyd2a antikoerper, smyd2b antikoerper
- Hintergrund
-
The specific function of this protein remains unknown.SET domain-containing proteins, such as SMYD2, catalyze lysine methylation (Brown et al., 2006 [PubMed 16805913]).[supplied by OMIM].
Alias Symbols: HSKM-B, KMT3C, MGC119305, ZMYND14
Protein Interaction Partner: UBC, HIST2H3C, HSP90AA1, RB1, EPB41L3, TP53, CLASP2, AKAP11, CDC37, IGF2BP1, AXIN1, GSK3B,
Protein Size: 433 - Molekulargewicht
- 50 kDa
- Gen-ID
- 56950
- NCBI Accession
- NM_020197, NP_064582
- UniProt
- Q9NRG4
-